OPTIMUM INVESTMENT ADVISORS - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 130 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.5%.

Quarter-by-quarter ownership
OPTIMUM INVESTMENT ADVISORS ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$4,000
-81.0%
300
-76.9%
0.00%
-85.7%
Q2 2019$21,000
-4.5%
1,3000.0%0.01%0.0%
Q1 2019$22,000
+22.2%
1,3000.0%0.01%
+16.7%
Q4 2018$18,000
-65.4%
1,300
-27.8%
0.01%
-57.1%
Q3 2018$52,0000.0%1,800
-5.3%
0.01%
-6.7%
Q2 2018$52,000
+30.0%
1,9000.0%0.02%
+25.0%
Q1 2018$40,0001,9000.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders